Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 134,986 251,929 319,053 656,089
Total Sell Value $11,097,511 $21,508,551 $27,661,182 $61,420,002
Total People Sold 5 6 7 7
Total Sell Transactions 9 19 27 56
End Date 2024-04-04 2024-01-02 2023-07-04 2022-07-04

   
Records found: 1285
  Page 34 of 52  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baffi Robert EVP, Technical Operations   •       –      –    2017-06-02 4 D $90.72 $149,144 D/D (1,644) 144,583     -
   Davis George Eric EVP, General Counsel   •       –      –    2017-06-02 4 D $90.72 $134,991 D/D (1,488) 83,813     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-06-02 4 D $90.72 $602,381 D/D (6,640) 226,924     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-06-02 4 AS $89.70 $448,500 D/D (5,000) 233,564     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-06-02 4 OE $17.33 $86,650 D/D 5,000 238,564     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-06-01 4 AS $87.53 $437,650 D/D (5,000) 233,564     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-06-01 4 OE $17.33 $86,650 D/D 5,000 238,564     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-05-31 4 AS $88.29 $655,377 D/D (7,423) 233,564     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-05-31 4 OE $17.33 $128,641 D/D 7,423 240,987     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-05-24 4 AS $88.38 $441,900 D/D (5,000) 233,564     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-05-24 4 OE $17.33 $86,650 D/D 5,000 238,564     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-05-17 4 AS $91.73 $458,650 D/D (5,000) 233,564     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-05-17 4 OE $17.33 $86,650 D/D 5,000 238,564     -
   Davis George Eric EVP, General Counsel   •       –      –    2017-05-16 4 OE $14.39 $16,491 D/D 1,146 85,301     -
   Davis George Eric EVP, General Counsel   •       –      –    2017-05-15 4 D $91.50 $100,284 D/D (1,096) 84,155     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-05-15 4 D $91.50 $451,278 D/D (4,932) 233,564     -
   Mueller Brian SVP, Corporate Controller   •       –      –    2017-05-15 4 D $91.50 $18,941 D/D (207) 13,261     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2017-05-15 4 D $91.50 $157,563 D/D (1,722) 25,104     -
   Baffi Robert EVP, Technical Operations   •       –      –    2017-05-15 4 D $91.50 $143,289 D/D (1,566) 146,227     -
   Fuchs Henry J President, Worldwide R&D   •       –      –    2017-05-15 4 D $91.50 $186,294 D/D (2,036) 138,458     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2017-05-15 4 D $91.50 $100,284 D/D (1,096) 50,436     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-05-12 4 AS $89.23 $446,150 D/D (5,000) 238,496     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-05-12 4 OE $17.33 $86,650 D/D 5,000 243,496     -
   Mueller Brian SVP, Corporate Controller   •       –      –    2017-05-08 4 AS $91.17 $687,334 D/D (7,482) 13,468     -
   Mueller Brian SVP, Corporate Controller   •       –      –    2017-05-08 4 OE $21.51 $55,926 D/D 2,600 16,068     -
  1285 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 34 of 52
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us